Vancomycin resistant enterococcus faecium infections – pipeline review, h2 2012

424 views

Published on

Aarkstore.com || Vancomycin-Resistant Enterococcus Faecium Infections || Market Research

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
424
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Vancomycin resistant enterococcus faecium infections – pipeline review, h2 2012

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Vancomycin-Resistant Enterococcus Faecium Infections –Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Vancomycin-Resistant Enterococcus Faecium Infections -Pipeline Review, H2 2012, provides an overview of the Vancomycin-ResistantEnterococcus Faecium Infections therapeutic pipeline. This report providesinformation on the therapeutic development for Vancomycin-ResistantEnterococcus Faecium Infections, complete with latest updates, and special featureson late-stage and discontinued projects. It also reviews key players involved in thetherapeutic development for Vancomycin-Resistant Enterococcus FaeciumInfections. Vancomycin-Resistant Enterococcus Faecium Infections - PipelineReview, H2 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Vancomycin-ResistantEnterococcus Faecium Infections.- A review of the Vancomycin-Resistant Enterococcus Faecium Infections productsunder development by companies and universities/research institutes based oninformation derived from company and industry-specific sources.
  2. 2. - Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 4List of Figures 5Introduction 6Global Markets Direct Report Coverage 6Vancomycin-Resistant Enterococcus Faecium Infections Overview 7Therapeutics Development 8An Overview of Pipeline Products for Vancomycin-Resistant Enterococcus FaeciumInfections 8Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics underDevelopment by Companies 10Late Stage Products 12Comparative Analysis 12Mid Clinical Stage Products 13Comparative Analysis 13Early Clinical Stage Products 14Comparative Analysis 14Discovery and Pre-Clinical Stage Products 15Comparative Analysis 15Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics – Productsunder Development by Companies 16Companies Involved in Vancomycin-Resistant Enterococcus Faecium InfectionsTherapeutics Development 17Ceragenix Pharmaceuticals, Inc. 17Piramal Healthcare Limited 18Wockhardt Limited 19Paratek Pharmaceuticals, Inc. 20Immtech Pharmaceuticals, Inc. 21Lorus Therapeutics Inc 22Oragenics, Inc. 23
  3. 3. MerLion Pharmaceuticals Pte Ltd 24MicuRx Pharmaceuticals, Inc. 25Trius Therapeutics, Inc. 26Vancomycin-Resistant Enterococcus Faecium Infections – Therapeutics Assessment27Assessment by Monotherapy Products 27Assessment by Route of Administration 28Assessment by Molecule Type 30Drug Profiles 32LOR-220 - Drug Profile 32Product Description 32Mechanism of Action 32R&D Progress 32List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1Myocardial Ischemia – Pipeline Review, H2 2012Primary Immune Deficiency (PID) – Pipeline Review, H2 2012Vancomycin-Resistant Enterococcus Faecium Infections – Pipeline Review, H2 2012
  4. 4. Intra Dialytic Hypotension – Pipeline Review, H2 2012Poisoning – Pipeline Review, H2 2012Edema – Pipeline Review, H2 2012Coronary Stenosis – Pipeline Review, H2 2012Hypoglycemia – Pipeline Review, H2 2012Nasopharyngitis (Common Cold) – Pipeline Review, H2 2012AIDS Associated Dementia – Pipeline Review, H2 2012Open-Angle Glaucoma – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×